Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elias A Said

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Sultan Qaboos University Medical Journal|April 22, 2011
The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?Elias A Said
Oman Medical Journal|April 3, 2023
Circadian Rhythm, Sleep, and Immune Response and the Fight against COVID-19Mohammed A Al-Abri, Saif Al-Yaarubi, Elias A Said
Vaccines|April 27, 2024
Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public HealthElias A Said, Alessandra Noto, Sylvain Cardinaud, et al.
The FEBS Journal|September 15, 2005
Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolinElias A Said, José Courty, Josette Svab, et al.
The Journal of Biological Chemistry|July 31, 2002
The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptorElias A Said, Bernard Krust, Sébastien Nisole, et al.
Journal of Immunology Research|June 2, 2018
Viruses Seen by Our Cells: The Role of Viral RNA SensorsElias A Said, Nicolas Tremblay, Mohammed S Al-Balushi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 22, 2021
Effects of Bacterial Metabolites on the Immune System: Enemies and FriendsZaaima Al-Jabri, Iman Al-Reesi, Nawal Al-Shizawi, et al.
Springer Seminars in Immunopathology|September 13, 2006
Generation and maintenance of human memory cells during viral infectionRabih Halwani, Mehrnoosh Doroudchi, Bader Yassine-Diab, et al.
Immunity|November 13, 2004
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infectionAra G Hovanessian, Jean-Paul Briand, Elias A Said, et al.
The Journal of Biological Chemistry|March 29, 2002
The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cellsSébastien Nisole, Elias A Said, Claudia Mische, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Sultan Qaboos University Medical Journal|April 22, 2011
The Need for New Anti-Hepatitis C Virus Therapeutic Strategies: Targeting the cellular micro-ribonucleic acids?Elias A Said
Oman Medical Journal|April 3, 2023
Circadian Rhythm, Sleep, and Immune Response and the Fight against COVID-19Mohammed A Al-Abri, Saif Al-Yaarubi, Elias A Said
Vaccines|April 27, 2024
Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public HealthElias A Said, Alessandra Noto, Sylvain Cardinaud, et al.
The FEBS Journal|September 15, 2005
Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolinElias A Said, José Courty, Josette Svab, et al.
The Journal of Biological Chemistry|July 31, 2002
The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptorElias A Said, Bernard Krust, Sébastien Nisole, et al.
Journal of Immunology Research|June 2, 2018
Viruses Seen by Our Cells: The Role of Viral RNA SensorsElias A Said, Nicolas Tremblay, Mohammed S Al-Balushi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|November 22, 2021
Effects of Bacterial Metabolites on the Immune System: Enemies and FriendsZaaima Al-Jabri, Iman Al-Reesi, Nawal Al-Shizawi, et al.
Springer Seminars in Immunopathology|September 13, 2006
Generation and maintenance of human memory cells during viral infectionRabih Halwani, Mehrnoosh Doroudchi, Bader Yassine-Diab, et al.
Immunity|November 13, 2004
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infectionAra G Hovanessian, Jean-Paul Briand, Elias A Said, et al.
The Journal of Biological Chemistry|March 29, 2002
The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cellsSébastien Nisole, Elias A Said, Claudia Mische, et al.
Pageof 4